Global Polio Vaccine Market Growth 2022-2028
As the global economy mends, the 2021 growth of Polio Vaccine will have significant change from previous year. According to our latest study, the global Polio Vaccine market size is USD million in 2022 from USD 694.4 million in 2021, with a change of % between 2021 and 2022. The global Polio Vaccine market size will reach USD 935.9 million in 2028, growing at a CAGR of 4.4% over the analysis period.
The United States Polio Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Polio Vaccine market, reaching US$ million by the year 2028. As for the Europe Polio Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Polio Vaccine players cover Sanofi, GSK, Bibcol, and Serum Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Public
Private
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Polio Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Polio Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Polio Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Polio Vaccine Segment by Type
2.2.1 Inactivated Polio Vaccine (IPV)
2.2.2 Oral Polio Vaccine (OPV)
2.3 Polio Vaccine Sales by Type
2.3.1 Global Polio Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Polio Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Polio Vaccine Sale Price by Type (2017-2022)
2.4 Polio Vaccine Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Polio Vaccine Sales by Application
2.5.1 Global Polio Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Polio Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Polio Vaccine Sale Price by Application (2017-2022)
3 Global Polio Vaccine by Company
3.1 Global Polio Vaccine Breakdown Data by Company
3.1.1 Global Polio Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Polio Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Polio Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Polio Vaccine Revenue by Company (2020-2022)
3.2.2 Global Polio Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Polio Vaccine Sale Price by Company
3.4 Key Manufacturers Polio Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polio Vaccine Product Location Distribution
3.4.2 Players Polio Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Polio Vaccine by Geographic Region
4.1 World Historic Polio Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Polio Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Polio Vaccine Annual Revenue by Geographic Region
4.2 World Historic Polio Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Polio Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Polio Vaccine Annual Revenue by Country/Region
4.3 Americas Polio Vaccine Sales Growth
4.4 APAC Polio Vaccine Sales Growth
4.5 Europe Polio Vaccine Sales Growth
4.6 Middle East & Africa Polio Vaccine Sales Growth
5 Americas
5.1 Americas Polio Vaccine Sales by Country
5.1.1 Americas Polio Vaccine Sales by Country (2017-2022)
5.1.2 Americas Polio Vaccine Revenue by Country (2017-2022)
5.2 Americas Polio Vaccine Sales by Type
5.3 Americas Polio Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polio Vaccine Sales by Region
6.1.1 APAC Polio Vaccine Sales by Region (2017-2022)
6.1.2 APAC Polio Vaccine Revenue by Region (2017-2022)
6.2 APAC Polio Vaccine Sales by Type
6.3 APAC Polio Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Polio Vaccine by Country
7.1.1 Europe Polio Vaccine Sales by Country (2017-2022)
7.1.2 Europe Polio Vaccine Revenue by Country (2017-2022)
7.2 Europe Polio Vaccine Sales by Type
7.3 Europe Polio Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Polio Vaccine by Country
8.1.1 Middle East & Africa Polio Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Polio Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Polio Vaccine Sales by Type
8.3 Middle East & Africa Polio Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polio Vaccine
10.3 Manufacturing Process Analysis of Polio Vaccine
10.4 Industry Chain Structure of Polio Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polio Vaccine Distributors
11.3 Polio Vaccine Customer
12 World Forecast Review for Polio Vaccine by Geographic Region
12.1 Global Polio Vaccine Market Size Forecast by Region
12.1.1 Global Polio Vaccine Forecast by Region (2023-2028)
12.1.2 Global Polio Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Polio Vaccine Forecast by Type
12.7 Global Polio Vaccine Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Polio Vaccine Product Offered
13.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Polio Vaccine Product Offered
13.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bibcol
13.3.1 Bibcol Company Information
13.3.2 Bibcol Polio Vaccine Product Offered
13.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bibcol Main Business Overview
13.3.5 Bibcol Latest Developments
13.4 Serum Institute
13.4.1 Serum Institute Company Information
13.4.2 Serum Institute Polio Vaccine Product Offered
13.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Serum Institute Main Business Overview
13.4.5 Serum Institute Latest Developments
13.5 Tiantan Biological
13.5.1 Tiantan Biological Company Information
13.5.2 Tiantan Biological Polio Vaccine Product Offered
13.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Tiantan Biological Main Business Overview
13.5.5 Tiantan Biological Latest Developments
13.6 IMBCA
13.6.1 IMBCA Company Information
13.6.2 IMBCA Polio Vaccine Product Offered
13.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 IMBCA Main Business Overview
13.6.5 IMBCA Latest Developments
13.7 Panacea Biotec Ltd
13.7.1 Panacea Biotec Ltd Company Information
13.7.2 Panacea Biotec Ltd Polio Vaccine Product Offered
13.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Panacea Biotec Ltd Main Business Overview
13.7.5 Panacea Biotec Ltd Latest Developments
13.8 Bio-Med
13.8.1 Bio-Med Company Information
13.8.2 Bio-Med Polio Vaccine Product Offered
13.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bio-Med Main Business Overview
13.8.5 Bio-Med Latest Developments
13.9 Halfkin Bio-Pharmaceuticals
13.9.1 Halfkin Bio-Pharmaceuticals Company Information
13.9.2 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offered
13.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.9.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Polio Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Polio Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Inactivated Polio Vaccine (IPV)
Table 4. Major Players of Oral Polio Vaccine (OPV)
Table 5. Global Polio Vaccine Sales by Type (2017-2022) & (M Doses)
Table 6. Global Polio Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Polio Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Polio Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Polio Vaccine Sale Price by Type (2017-2022) & (USD/K Doses)
Table 10. Global Polio Vaccine Sales by Application (2017-2022) & (M Doses)
Table 11. Global Polio Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Polio Vaccine Revenue by Application (2017-2022)
Table 13. Global Polio Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Polio Vaccine Sale Price by Application (2017-2022) & (USD/K Doses)
Table 15. Global Polio Vaccine Sales by Company (2020-2022) & (M Doses)
Table 16. Global Polio Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Polio Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Polio Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Polio Vaccine Sale Price by Company (2020-2022) & (USD/K Doses)
Table 20. Key Manufacturers Polio Vaccine Producing Area Distribution and Sales Area
Table 21. Players Polio Vaccine Products Offered
Table 22. Polio Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Polio Vaccine Sales by Geographic Region (2017-2022) & (M Doses)
Table 26. Global Polio Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Polio Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Polio Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Polio Vaccine Sales by Country/Region (2017-2022) & (M Doses)
Table 30. Global Polio Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Polio Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Polio Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Polio Vaccine Sales by Country (2017-2022) & (M Doses)
Table 34. Americas Polio Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Polio Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Polio Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Polio Vaccine Sales by Type (2017-2022) & (M Doses)
Table 38. Americas Polio Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Polio Vaccine Sales by Application (2017-2022) & (M Doses)
Table 40. Americas Polio Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Polio Vaccine Sales by Region (2017-2022) & (M Doses)
Table 42. APAC Polio Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Polio Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Polio Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Polio Vaccine Sales by Type (2017-2022) & (M Doses)
Table 46. APAC Polio Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Polio Vaccine Sales by Application (2017-2022) & (M Doses)
Table 48. APAC Polio Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Polio Vaccine Sales by Country (2017-2022) & (M Doses)
Table 50. Europe Polio Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Polio Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Polio Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Polio Vaccine Sales by Type (2017-2022) & (M Doses)
Table 54. Europe Polio Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Polio Vaccine Sales by Application (2017-2022) & (M Doses)
Table 56. Europe Polio Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Polio Vaccine Sales by Country (2017-2022) & (M Doses)
Table 58. Middle East & Africa Polio Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Polio Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Polio Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Polio Vaccine Sales by Type (2017-2022) & (M Doses)
Table 62. Middle East & Africa Polio Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Polio Vaccine Sales by Application (2017-2022) & (M Doses)
Table 64. Middle East & Africa Polio Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Polio Vaccine
Table 66. Key Market Challenges & Risks of Polio Vaccine
Table 67. Key Industry Trends of Polio Vaccine
Table 68. Polio Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Polio Vaccine Distributors List
Table 71. Polio Vaccine Customer List
Table 72. Global Polio Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 73. Global Polio Vaccine Sales Market Forecast by Region
Table 74. Global Polio Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Polio Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Polio Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 77. Americas Polio Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Polio Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
Table 79. APAC Polio Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Polio Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 81. Europe Polio Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Polio Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
Table 83. Middle East & Africa Polio Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Polio Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
Table 85. Global Polio Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Polio Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Polio Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Polio Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
Table 89. Global Polio Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Polio Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Polio Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Polio Vaccine Product Offered
Table 94. Sanofi Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. GSK Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Polio Vaccine Product Offered
Table 99. GSK Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Bibcol Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Bibcol Polio Vaccine Product Offered
Table 104. Bibcol Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 105. Bibcol Main Business
Table 106. Bibcol Latest Developments
Table 107. Serum Institute Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Serum Institute Polio Vaccine Product Offered
Table 109. Serum Institute Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 110. Serum Institute Main Business
Table 111. Serum Institute Latest Developments
Table 112. Tiantan Biological Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Tiantan Biological Polio Vaccine Product Offered
Table 114. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 115. Tiantan Biological Main Business
Table 116. Tiantan Biological Latest Developments
Table 117. IMBCA Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. IMBCA Polio Vaccine Product Offered
Table 119. IMBCA Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 120. IMBCA Main Business
Table 121. IMBCA Latest Developments
Table 122. Panacea Biotec Ltd Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Panacea Biotec Ltd Polio Vaccine Product Offered
Table 124. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 125. Panacea Biotec Ltd Main Business
Table 126. Panacea Biotec Ltd Latest Developments
Table 127. Bio-Med Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Bio-Med Polio Vaccine Product Offered
Table 129. Bio-Med Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 130. Bio-Med Main Business
Table 131. Bio-Med Latest Developments
Table 132. Halfkin Bio-Pharmaceuticals Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offered
Table 134. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2020-2022)
Table 135. Halfkin Bio-Pharmaceuticals Main Business
Table 136. Halfkin Bio-Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Polio Vaccine
Figure 2. Polio Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polio Vaccine Sales Growth Rate 2017-2028 (M Doses)
Figure 7. Global Polio Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Polio Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Inactivated Polio Vaccine (IPV)
Figure 10. Product Picture of Oral Polio Vaccine (OPV)
Figure 11. Global Polio Vaccine Sales Market Share by Type in 2021
Figure 12. Global Polio Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Polio Vaccine Consumed in Public
Figure 14. Global Polio Vaccine Market: Public (2017-2022) & (M Doses)
Figure 15. Polio Vaccine Consumed in Private
Figure 16. Global Polio Vaccine Market: Private (2017-2022) & (M Doses)
Figure 17. Global Polio Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Polio Vaccine Revenue Market Share by Application in 2021
Figure 19. Polio Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Polio Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Polio Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Polio Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Polio Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Polio Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Polio Vaccine Sales 2017-2022 (M Doses)
Figure 26. Americas Polio Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Polio Vaccine Sales 2017-2022 (M Doses)
Figure 28. APAC Polio Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Polio Vaccine Sales 2017-2022 (M Doses)
Figure 30. Europe Polio Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Polio Vaccine Sales 2017-2022 (M Doses)
Figure 32. Middle East & Africa Polio Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Polio Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Polio Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Polio Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Polio Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Polio Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Polio Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Polio Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Polio Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Polio Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Polio Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Polio Vaccine
Figure 63. Industry Chain Structure of Polio Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
